Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses

Vaccine

Volumn 25, Issue 14, 2007, Pages 2591-2598

  Nyström, Johanna ^a   Svennerholm, Ann Mari ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

H. pylori; HpaA; Mice; Mucosal immune responses; Therapeutic immunization

Indexed keywords

HELICOBACTER PYLORI ADHESIN A VACCINE; HELICOBACTER PYLORI VACCINE; IMMUNOGLOBULIN A; UNCLASSIFIED DRUG; UREASE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; HELICOBACTER PYLORI; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS;

ADHESINS, BACTERIAL; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; CYTOKINES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNITY, MUCOSAL; IMMUNIZATION; IMMUNOGLOBULIN A, SECRETORY; MICE; MICE, INBRED C57BL; STOMACH;

EID: 33947177581     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.12.026     Document Type: Article

References (40)

1. Blaser M.J. Helicobacter pylori and the pathogenesis of gastroduodenal inflammation. J Infect Dis 161 April (4) (1990) 626-633
2. Wong B.C., Lam S.K., Lai K.C., Hu W.H., Ching C.K., Ho J., et al. Triple therapy for Helicobacter pylori eradication is more effective than long-term maintenance antisecretory treatment in the prevention of recurrence of duodenal ulcer: a prospective long-term follow-up study. Aliment Pharmacol Ther 13 March (3) (1999) 303-309
3. Boyanova L., Mentis A., Gubina M., Rozynek E., Gosciniak G., Kalenic S., et al. The status of antimicrobial resistance of Helicobacter pylori in eastern Europe. Clin Microbiol Infect 8 July (7) (2002) 388-396
4. Koletzko S., Richy F., Bontems P., Crone J., Kalach N., Monteiro M.L., et al. Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe. Gut April 7 (2006)
5. Wheeldon T.U., Hoang T.T., Phung D.C., Bjorkman A., Granstrom M., and Sorberg M. Long-term follow-up of Helicobacter pylori eradication therapy in Vietnam: reinfection and clinical outcome. Aliment Pharmacol Ther 21 8 (2005) 1047-1053
6. Nystrom J., Raghavan S., and Svennerholm A.M. Mucosal immune responses are related to reduction of bacterial colonization in the stomach after therapeutic Helicobacter pylori immunization in mice. Microbes Infect September (2005)
7. Raghavan S., Svennerholm A.M., and Holmgren J. Effects of oral vaccination and immunomodulation by cholera toxin on experimental Helicobacter pylori infection, reinfection, and gastritis. Infect Immun 70 August (8) (2002) 4621-4627
8. Czinn S.J., and Nedrud J.G. Oral immunization against Helicobacter pylori. Infect Immun 59 July (7) (1991) 2359-2363
9. Pappo J., Torrey D., Castriotta L., Savinainen A., Kabok Z., and Ibraghimov A. Helicobacter pylori infection in immunized mice lacking major histocompatibility complex class I and class II functions. Infect Immun 67 January (1) (1999) 337-341
10. Ermak T.H., Giannasca P.J., Nichols R., Myers G.A., Nedrud J., Weltzin R., et al. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J Exp Med 188 December (12) (1998) 2277-2288
11. Tsuda M., Karita M., Mizote T., Morshed M.G., Okita K., and Nakazawa T. Essential role of Helicobacter pylori urease in gastric colonization: definite proof using a urease-negative mutant constructed by gene replacement. Eur J Gastroenterol Hepatol 6 December (Suppl. 1) (1994) S49-S52
12. Corthesy-Theulaz I.E., Hopkins S., Bachmann D., Saldinger P.F., Porta N., Haas R., et al. Mice are protected from Helicobacter pylori infection by nasal immunization with attenuated Salmonella typhimurium phoPc expressing urease A and B subunits. Infect Immun 66 February (2) (1998) 581-586
13. Blaser M.J., Perez-Perez G.I., Kleanthous H., Cover T.L., Peek R.M., Chyou P.H., et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 55 May (10) (1995) 2111-2115
14. Ghiara P., Rossi M., Marchetti M., Di Tommaso A., Vindigni C., Ciampolini F., et al. Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect Immun 65 December (12) (1997) 4996-5002
15. Satin B., Del Giudice G., Della Bianca V., Dusi S., Laudanna C., Tonello F., et al. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med 191 May (9) (2000) 1467-1476
16. Hazell S.L., Evans Jr. D.J., and Graham D.Y. Helicobacter pylori catalase. J Gen Microbiol 137 January (1) (1991) 57-61
17. Yan J., Mao Y.F., and Shao Z.X. Frequencies of the expression of main protein antigens from Helicobacter pylori isolates and production of specific serum antibodies in infected patients. World J Gastroenterol 11 January (3) (2005) 421-425
18. Bolin I., Lonroth H., and Svennerholm A.M. Identification of Helicobacter pylori by immunological dot blot method based on reaction of a species-specific monoclonal antibody with a surface-exposed protein. J Clin Microbiol 33 February (2) (1995) 381-384
19. Evans D.G., Evans Jr. D.J., Moulds J.J., and Graham D.Y. N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen. Infect Immun 56 November (11) (1988) 2896-2906
20. Blom K., Lundin B.S., Bolin I., and Svennerholm A. Flow cytometric analysis of the localization of Helicobacter pylori antigens during different growth phases. FEMS Immunol Med Microbiol 30 April (3) (2001) 173-179
21. Lundstrom A.M., Blom K., Sundaeus V., and Bolin I. HpaA shows variable surface localization but the gene expression is similar in different Helicobacter pylori strains. Microb Pathog 31 November (5) (2001) 243-253
22. O'Toole P.W., Janzon L., Doig P., Huang J., Kostrzynska M., and Trust T.J. The putative neuraminyllactose-binding hemagglutinin HpaA of Helicobacter pylori CCUG 17874 is a lipoprotein. J Bacteriol 177 November (21) (1995) 6049-6057
23. Carlsohn E., Nystrom J., Bolin I., Nilsson C.L., and Svennerholm A.M. HpaA is essential for Helicobacter pylori colonization in mice. Infect Immun 74 February (2) (2006) 920-926
24. Mattsson A., Tinnert A., Hamlet A., Lonroth H., Bolin I., and Svennerholm A.M. Specific antibodies in sera and gastric aspirates of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Clin Diagn Lab Immunol 5 May (3) (1998) 288-293
25. Lee A., O'Rourke J., De Ungria M.C., Robertson B., Daskalopoulos G., and Dixon M.F. A standardized mouse model of Helicobacter pylori infection: introducing the Sydney strain. Gastroenterology 112 April (4) (1997) 1386-1397
26. Lindholm C., Osek J., and Svennerholm A.M. Quantification of conserved antigens in Helicobacter pylori during different culture conditions. Infect Immun 65 December (12) (1997) 5376-5380
27. Lundstrom A.M., Bolin I., Bystrom M., and Nystrom S. Recombinant HpaA purified from Escherichia coli has biological properties similar to those of native Helicobacter pylori HpaA. Apmis 111 March (3) (2003) 389-397
28. Radcliff F.J., Hazell S.L., Kolesnikow T., Doidge C., and Lee A. Catalase, a novel antigen for Helicobacter pylori vaccination. Infect Immun 65 November (11) (1997) 4668-4674
29. Thoreson A.C., Hamlet A., Celik J., Bystrom M., Nystrom S., Olbe L., et al. Differences in surface-exposed antigen expression between Helicobacter pylori strains isolated from duodenal ulcer patients and from asymptomatic subjects. J Clin Microbiol 38 September (9) (2000) 3436-3441
30. Raghavan S., Hjulstrom M., Holmgren J., and Svennerholm A.M. Protection against experimental Helicobacter pylori infection after immunization with inactivated H. pylori whole-cell vaccines. Infect Immun 70 November (11) (2002) 6383-6388
31. Johansson E.L., Rask C., Fredriksson M., Eriksson K., Czerkinsky C., and Holmgren J. Antibodies and antibody-secreting cells in the female genital tract after vaginal or intranasal immunization with cholera toxin B subunit or conjugates. Infect Immun 66 February (2) (1998) 514-520
32. Saldinger P.F., Porta N., Launois P., Louis J.A., Waanders G.A., Bouzourene H., et al. Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection. Gastroenterology 115 October (4) (1998) 891-897
33. Akhiani A.A., Pappo J., Kabok Z., Schon K., Gao W., Franzen L.E., et al. Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells. J Immunol 169 December (12) (2002) 6977-6984
34. Suerbaum S., and Michetti P. Helicobacter pylori infection. N Engl J Med 347 October (15) (2002) 1175-1186
35. Wirth H.P., Beins M.H., Yang M., Tham K.T., and Blaser M.J. Experimental infection of Mongolian gerbils with wild-type and mutant Helicobacter pylori strains. Infect Immun 66 October (10) (1998) 4856-4866
36. Voland P., Hafsi N., Zeitner M., Laforsch S., Wagner H., and Prinz C. Antigenic properties of HpaA and Omp18, two outer membrane proteins of Helicobacter pylori. Infect Immun 71 July (7) (2003) 3837-3843
37. Mattsson A., Quiding-Jarbrink M., Lonroth H., Hamlet A., Ahlstedt I., and Svennerholm A. Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Infect Immun 66 June (6) (1998) 2705-2712
38. Azem J., Svennerholm A.M., and Lundin B.S. B cells pulsed with Helicobacter pylori antigen efficiently activate memory CD8(+) T cells from H. pylori-infected individuals. Clin Immunol November (2005)
39. Koesling J., Lucas B., Develioglou L., Aebischer T., and Meyer T.F. Vaccination of mice with live recombinant Salmonella typhimurium aroA against H. pylori: parameters associated with prophylactic and therapeutic vaccine efficacy. Vaccine 20 November (3-4) (2001) 413-420
40. Sanchez V., Gimenez S., Haensler J., Geoffroy C., Rokbi B., Seguin D., et al. Formulations of single or multiple H. pylori antigens with DC Chol adjuvant induce protection by the systemic route in mice. Optimal prophylactic combinations are different from therapeutic ones. FEMS Immunol Med Microbiol 30 March (2) (2001) 157-165